Moreover, for different cancer types this filter needs to be adapted accordingly, e.g. hotspot mutations would be missed by this such as BRAF V600E, found in 35% melanoma patients [50], and specific genes were recurrently mutated in 20% DLBCL patients [51], requiring a higher threshold. The gene discussed is BRAF; the disease is cancer.